LAB
STANDARD BIOTOOLS INC.Company Information
- Company Name
- STANDARD BIOTOOLS INC.
- CIK
- CIK0001162194
- Category
- Accelerated filer
- Ticker: Exchange
- LAB: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- LAB
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-03
- Last sale
- 2025-05-23
- Shares purchased (TTM)
- 14,120,959
- Shares sold (TTM)
- 45,251
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 295,905,524
- Shares outstanding
- 390,881,000
- Ownership
- 75.70%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -17.95%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 270 | 266 | 121 | 129 | 159 | 151 | 167 | 211 | 270 | 287 | 52 | 80 | ||||||
| Available For Sale Securities Debt Securities Current | 207 | 189 | 67 | 65 | 78 | 107 | 126 | 156 | 125 | 175 | 63 | 49 | ||||||
| Accounts Receivable Net Current | 16 | 17 | 13 | 14 | 15 | 35 | 15 | 35 | 32 | 36 | 20 | 17 | ||||||
| Inventory Net | 17 | 19 | 20 | 25 | 24 | 42 | 21 | 43 | 43 | 40 | 21 | 22 | ||||||
| Prepaid Expense And Other Assets Current | 7 | 6 | 5 | 8 | 7 | 8 | 5 | 9 | 10 | 9 | 3 | 3 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | 0 | 0 | 228 | 231 | 223 | - | 43 | - | - | - | - | - | ||||||
| Assets Current | 517 | 521 | 454 | 472 | 506 | 344 | 376 | 454 | 480 | 548 | 158 | 171 | ||||||
| Inventory Noncurrent | - | - | - | - | - | 18 | 19 | 18 | 16 | 13 | 0 | - | ||||||
| Property Plant And Equipment Net | 15 | 17 | 19 | 21 | 23 | 44 | 23 | 42 | 43 | 45 | 24 | 25 | ||||||
| Operating Lease Right Of Use Asset | 24 | 26 | 27 | 23 | 25 | 27 | 27 | 30 | 32 | 33 | 31 | 31 | ||||||
| Other Assets Noncurrent | 3 | 3 | 3 | 4 | 4 | 7 | 4 | 5 | 4 | 4 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | 28 | 29 | 23 | 24 | 25 | 1 | 4 | ||||||
| Goodwill | - | - | - | - | - | 112 | 111 | 106 | 106 | 106 | 106 | 106 | ||||||
| Long Term Investments | 67 | 71 | 26 | 19 | - | - | 0 | - | - | - | - | - | ||||||
| Deferred Income Tax Assets Net | 0 | 0 | 39 | - | - | - | 0 | - | - | - | - | - | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | 0 | 0 | 0 | - | 183 | - | - | - | - | - | ||||||
| Assets | 627 | 639 | 568 | 540 | 557 | 580 | 612 | 682 | 709 | 778 | 323 | 339 | ||||||
Liabilities Current | ||||||||||||||||||
| Employee Related Liabilities Current | - | - | - | - | - | - | - | - | - | - | 12 | 10 | ||||||
| Accounts Payable Current | 10 | 8 | 5 | 7 | 7 | 12 | 5 | 11 | 13 | 13 | 9 | 7 | ||||||
| Accrued Liabilities Current | 30 | 16 | 30 | 31 | 24 | 22 | 21 | 32 | 32 | 30 | 21 | 10 | ||||||
| Operating Lease Liability Current | 6 | 6 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | 6 | 4 | 4 | ||||||
| Contract With Customer Liability Current | 9 | 10 | 39 | 40 | 40 | 13 | 10 | 13 | 15 | 14 | 12 | 11 | ||||||
| Secured Debt Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 5 | 5 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | 0 | 0 | 26 | 22 | 18 | - | 21 | - | - | - | - | - | ||||||
| Convertible Debt Current | - | - | - | - | - | - | 0 | 55 | 55 | 55 | 55 | - | ||||||
| Liabilities Current | 57 | 42 | 108 | 108 | 98 | 56 | 66 | 121 | 124 | 122 | 109 | 52 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 55 | ||||||
| Convertible Debt Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Secured Long Term Debt | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 3 | 5 | ||||||
| Operating Lease Liability Noncurrent | 22 | 24 | 25 | 22 | 23 | 25 | 26 | 28 | 30 | 31 | 30 | 31 | ||||||
| Contract With Customer Liability Noncurrent | 3 | 3 | 4 | 2 | 3 | 33 | 33 | 33 | 33 | 34 | 4 | 3 | ||||||
| Other Liabilities Noncurrent | 1 | 4 | 1 | 1 | 1 | 3 | 1 | 2 | 2 | 3 | 1 | 1 | ||||||
| Disposal Group Including Discontinued Operation Other Noncurrent Liabilities | - | - | - | 0 | 0 | - | 7 | - | - | - | - | - | ||||||
| Liabilities | 87 | 78 | 143 | 140 | 132 | 125 | 141 | 192 | 198 | 200 | 160 | 160 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 311 | 311 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1,745 | 1,741 | 1,732 | 1,726 | 1,718 | 1,711 | 1,702 | 1,688 | 1,682 | 1,675 | 861 | 857 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | -1 | -1 | -0 | -2 | 1 | 1 | -1 | -2 | -2 | -2 | -2 | ||||||
| Retained Earnings Accumulated Deficit | -1,160 | -1,133 | -1,261 | -1,280 | -1,245 | -1,212 | -1,186 | -1,152 | -1,125 | -1,079 | -1,001 | -981 | ||||||
| Treasury Stock Common Value | -46 | -46 | -46 | -46 | -46 | -46 | -46 | -46 | -46 | -17 | -6 | -6 | ||||||
| Stockholders Equity | 540 | 561 | 424 | 400 | 425 | 455 | 472 | 489 | 510 | 577 | -148 | -132 | ||||||
| Liabilities And Stockholders Equity | 627 | 639 | 568 | 540 | 557 | 580 | 612 | 682 | 709 | 778 | 323 | 339 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 400 | 400 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Common Stock Shares Issued | 411 | 409 | 405 | 402 | 400 | 398 | 396 | 391 | 390 | 388 | 83 | 83 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Shares Outstanding | 392 | 390 | 386 | 384 | 382 | 379 | 378 | 372 | 371 | 380 | 80 | 79 | ||||||
| Temporary Equity Liquidation Preference | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 256 | 256 | ||||||
| Treasury Stock Common Shares | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 7 | 3 | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSTANDARD BIOTOOLS INC. (LAB) — SEC Financial Statements & Analysis
STANDARD BIOTOOLS INC. (LAB) is a pharmaceutical preparations company, incorporated in DE. STANDARD BIOTOOLS INC. trades on Nasdaq as: LAB. STANDARD BIOTOOLS INC. (LAB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, STANDARD BIOTOOLS INC. carries a market cap of $320.52M, a P/E ratio of 3.78x, a P/B ratio of 0.59x, a P/S ratio of 3.79x, an enterprise value of $48.70M, and an EV/EBITDA multiple of -0.54x. On profitability, it posts a gross margin of 50.49%, an operating margin of -112.85%, a net margin of 100.37%, a Return on Equity (ROE) of 17.61%, a Return on Assets (ROA) of 14.34%, and a Return on Invested Capital (ROIC) of -35.70%. Per share, it reports EPS of $0.22, diluted EPS of $0.22, free cash flow per share of $-0.21, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 30.23% year-over-year, net income growth of -150.99% year-over-year, and EPS growth of -149.64% year-over-year. On the balance sheet, it maintains a current ratio of 9.10x, a quick ratio of 8.67x, working capital of $460.06M, a debt-to-equity ratio of 0.16x, a debt ratio of 0.14, an interest coverage ratio of -126.16x, free cash flow of $-82.58M (TTM), and net debt of $-271.82M. Figures sourced from SEC EDGAR.
- Market Cap
- $320.52M
- P/E TTM
- 3.78x
- EPS TTM
- $0.22
- P/B TTM
- 0.59x
- ROE TTM
- 17.61%
- ROA TTM
- 14.34%
- Debt To Equity
- 0.16x
- Free Cash Flow TTM
- $-82.58M
- Net Revenue TTM Growth 1Y
- 30.23%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is STANDARD BIOTOOLS INC. in?
STANDARD BIOTOOLS INC. (LAB) operates in the Pharmaceutical Preparations industry.
What exchange does LAB trade on?
STANDARD BIOTOOLS INC. (LAB) trades on the Nasdaq.
Where is STANDARD BIOTOOLS INC. incorporated?
STANDARD BIOTOOLS INC. is incorporated in DE.
When was STANDARD BIOTOOLS INC. (LAB)'s most recent SEC filing?
STANDARD BIOTOOLS INC. (LAB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is LAB's market cap?
STANDARD BIOTOOLS INC. (LAB) has a market capitalization of $320.52M as of 2026-06-30.
What is LAB's P/E ratio?
STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month P/E ratio is 3.78x as of 2026-06-30.
What is LAB's EPS (earnings per share)?
STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month EPS is $0.22 as of 2026-06-30.
What is LAB's ROE (return on equity)?
STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month Return on Equity (ROE) is 17.61% as of 2026-06-30.
What is LAB's ROA (return on assets)?
STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month Return on Assets (ROA) is 14.34% as of 2026-06-30.
What is LAB's ROIC (return on invested capital)?
STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month Return on Invested Capital (ROIC) is -35.70% as of 2026-06-30.
What is LAB's EV/EBITDA?
STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month EV/EBITDA is -0.54x as of 2026-06-30.